Decoration of polymeric micelles with cancer-specific peptide ligands for active targeting of paclitaxel
Source abstract
Abstract
Polymeric micelles based on poly(ethylene oxide)-b-poly(ε-caprolactone) PEO-b-PCL or poly(ethylene oxide)-b-poly(α-benzyl carboxylate-ε-caprolactone) PEO-b-PBCL block copolymers were prepared and decorated with either c(RGDfK) or p160, a cancer cell-specific peptide ligand, on their surface. The cellular uptake of p160-decorated PEO-b-PBCL micelles containing DiI fluorescent label by MDA-MB-435 cancer cells was assessed and compared to that for c(RGDfK)-decorated micelles. The hydrophobic anticancer drug paclitaxel (PTX) was physically encapsulated into PEO-b-PCL or PEO-b-PBCL micelles (with and without peptide ligands) using a dialysis technique. The effect of the micellar formulation on the specificity of encapsulated PTX against cancer cells was assessed by investigating the in vitro cytotoxicity of free and encapsulated PTX against MDA-MB-435 cancer cell line versus two normal cells, Human Umbilical Vein Endothelial Cells (HUVEC) and MCF10A cells, using the MTT assay. Our results showed both peptide ligands to facilitate the association of micelles with MDA-MB-435 cells. The p160-micelles, however showed better binding and internalizing in MDA-MB-435 cells than c(RGDfK)-micelles. In general, peptide decoration enhanced the selective cytotoxicity of encapsulated PTX against MDA-MB-435 cells over normal HUVEC and MCF10A cells. The extent of this increase in cancer cell specificity for encapsulated PTX was more for p160-decorated micelles than c(RGDfK)-decorated ones.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics · Radiopharmaceutical Chemistry and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (33)
Show source-provided references
1. RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature10.1016/j.drup.2005.10.002 ↗
2. From combinatorial chemistry to cancer-targeting peptides10.1021/mp700073y ↗
3. Therapeutic cancer targeting peptides10.1002/bip.10257 ↗
4. Cancer treatment by targted drug delivery to tumor vasculature in a mouse model10.1126/science.279.5349.377 ↗
5. Synthesis and biological evaluation of dimeric RGD peptide-paclitaxel conjugate as a model for integrin-targeted drug delivery10.1021/jm049165z ↗
6. Conjugated platinum(IV)-peptide complexes for targeting angiogenic tumor vasculature10.1021/bc070031k ↗
7. cRGD-functionalized polymer micelles for targeted doxorubicin delivery10.1002/anie.200460800 ↗
8. Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin10.1016/S0168-3659(03)00240-2 ↗
9. Enhanced intracellular uptake of sterically stabilized liposomal Doxorubicin in vitro resulting in improved antitumor activity in vivo10.1007/s11095-005-4588-x ↗
10. Intracellular delivery of doxorubicin with RGD-modified sterically stabilized liposomes for an improved antitumor efficacy: in vitro and in vivo10.1002/jps.20397 ↗
11. Enhanced intracellular delivery and improved antitumor efficacy of doxorubicin by sterically stabilized liposomes modified with a synthetic RGD mimetic10.1016/j.jconrel.2005.03.030 ↗
12. Preparation of doxorubicin-loaded stealth liposomes modified with RGD mimetic and cellular association in vitro
13. Arg-Gly-Asp (RGD) peptide conjugated poly(lactic acid)-poly(ethylene oxide) micelle for targeted drug delivery10.1002/jbm.a.31615 ↗
14. Binding and internalization of NGR-peptide-targeted liposomal doxorubicin (TVT-DOX) in CD13-expressing cells and its antitumor effects10.1097/CAD.0b013e3282a213ce ↗
15. Targeting liposomal chemotherapy via both tumor cell-specific and tumor vasculature-specific ligands potentiates therapeutic efficacy10.1158/0008-5472.CAN-06-2117 ↗
16. Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy
17. Design of superactive and selective integrin receptor antagonists containing the RGD sequence10.1007/BF00119142 ↗
18. Structural and functional aspects of RGD-containing cyclic pentapeptides as highly potent and selective integrin v 3 antagonists10.1021/ja9603721 ↗
19. Integrin alpha V beta 3 as a target for treatment of rheumatoid arthritis and related rheumatic diseases10.1136/ard.61.suppl_2.ii96 ↗
20. Inhibition of alpha(v)beta3 integrin reduces angiogenesis, bone turnover, and tumor cell proliferation in experimental prostate cancer bone metastases10.1023/A:1025461507027 ↗
21. Differential binding of drugs containing the NGR motif to CD13 isoforms in tumor vessels, epithelia, and myeloid cells
22. Structure-activity relationships of linear and cyclic peptides containing the NGR tumor-homing motif10.1074/jbc.M207500200 ↗
23. Neuroblastoma tumor cell-binding peptides identified through random peptide phage display10.1016/S0304-3835(01)00575-4 ↗
24. Novel self-associating poly(ethylene oxide)-b-poly(epsilon-caprolactone) based drug conjugates and nano-containers for paclitaxel delivery10.1016/j.ijpharm.2010.01.015 ↗
25. Conjugation of arginine-glycine-aspartic acid peptides to poly(ethylene oxide)-b-poly(epsilon-caprolactone) micelles for enhanced intracellular drug delivery to metastatic tumor cells10.1021/bm060967g ↗
26. Multifunctional polymeric micelles for enhanced intracellular delivery of doxorubicin to metastatic cancer cells10.1007/s11095-008-9673-5 ↗
27. The effect of block copolymer structure on the internalization of polymeric micelles by human breast cancer cells10.1016/j.colsurfb.2005.07.008 ↗
28. Paclitaxel prodrugs with sustained release and high solubility in poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelle nanocarriers: pharmacokinetic disposition, tolerability, and cytotoxicity10.1007/s11095-007-9451-9 ↗
29. Preclinical evaluation of the breast cancer cell-binding peptide, p16010.1158/1078-0432.CCR-05-0432 ↗
30. Translocation of liposomes into cancer cells by cell-penetrating peptides penetratin and tat: a kinetic and efficacy study10.1124/mol.62.4.864 ↗
31. Paclitaxel-loaded polymeric micelles modified with MCF-7 cell-specific phage protein: enhanced binding to target cancer cells and increased cytotoxicity10.1021/mp1001125 ↗
32. Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with paclitaxel10.1016/j.jconrel.2009.08.011 ↗
33. Cyclic RGDyK conjugation facilitates intracellular drug delivery of polymeric micelles to integrin-overexpressing tumor cells and neovasculature10.3109/10611861003663531 ↗